Last update: Dec. 8, 2017


Very Low Risk for breastfeeding

Safe. Compatible.
Minimal risk for breastfeeding and infant.

An anti-enkephalin that decreases intestinal secretion.

Since the latest update, we have not found published data on its excretion in breast milk.

Its high percentage of protein binding makes it unlikely it will transfer to milk in significant quantities.

Possible side effects are not serious or frequent.

Its use is authorized in infants from 3 months of age (Pediamecum 2015)

Its indiscriminate use in treating gastroenteritis is not justified. Most cases of gastroenteritis do not require medication: good hydration is sufficient, even more so in the case of a breastfeeding mother.


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.


Main tradenames from several countries containing Racécadotril in its composition:


Variable Value Unit
Molecular weight 386 daltons
Protein Binding 90 %
Tmax 2 hours
T1/2 3 hours


  1. AEMPS. Racecadotrilo. Ficha técnica. 2017 Full text (in our servers)
  2. Comité de Medicamentos de la Asociación Española de Pediatría. Racecadotrilo. Pediamécum. 2015 Full text (in our servers)
  3. MRI Index. Racecadotril. Drug Summary. 2007 Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM